Clinical Trials Directory

Trials / Unknown

UnknownNCT05945420

Adding Desmopressin to Tamsulosin for Treatment of BPH

Outcome of Adding Desmopressin to Tamsulosin for Treatment of Nocturnal Polyurea in Patients With Benign Prostatic Obstruction

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
160 (estimated)
Sponsor
Mansoura University · Academic / Other
Sex
Male
Age
50 Years – 80 Years
Healthy volunteers
Accepted

Summary

In this study investigators will add desmopressin for treatment of patients with benign prostatic hyperplasia and nocturnal polyurea

Detailed description

Investigators will give a group of patients tamsulosin and desmopressin and the other group will take tamsulosin and placepo and compare the outcome regarding symptoms of being prostatic hyperplasia especially nocturia and the effect on nocturnal polyurea in patients

Conditions

Interventions

TypeNameDescription
DRUGDesmopressin AcetateThis arm will receive tamsulosin and desmopressin acetate daily a
DRUGPlaceboThis arm will receive tamsulosin and placebo

Timeline

Start date
2023-07-20
Primary completion
2024-01-10
Completion
2024-02-10
First posted
2023-07-14
Last updated
2023-07-14

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05945420. Inclusion in this directory is not an endorsement.